•
Jun 30, 2022

The Joint Q2 2022 Earnings Report

The Joint Corp. reported second quarter results with revenue growth of 24%, system-wide sales growth of 21%, and system-wide comp sales growth of 8% compared to Q2 2021.

Key Takeaways

The Joint Corp. reported revenue of $25.1 million, a net income of $345,000, and earnings per diluted share of $0.02 for the second quarter of 2022. The company opened 34 clinics, bringing the total to 769, and sold 24 franchise licenses.

Revenue increased to $25.1 million, a 24% increase compared to Q2 2021.

Net income was $345,000, or $0.02 per diluted share, compared to $2.7 million, or $0.18 per diluted share, in Q2 2021.

The company opened 34 clinics, bringing the total clinic count to 769.

24 franchise licenses were sold, bringing the year-to-date total to 46.

Total Revenue
$25.1M
Previous year: $20.2M
+23.9%
EPS
$0.02
Previous year: $0.18
-88.9%
Gross Profit
$22.6M
Previous year: $18.2M
+24.5%
Cash and Equivalents
$9.4M
Previous year: $18.5M
-49.2%
Free Cash Flow
-$608K
Previous year: $5.84M
-110.4%
Total Assets
$87.1M
Previous year: $78.5M
+11.0%

The Joint

The Joint

Forward Guidance

Management reaffirmed its 2022 guidance.